Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Inventory: 2010-2025

Historic Inventory for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $203.2 million.

  • BIO-TECHNE's Inventory rose 9.81% to $203.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $203.2 million, marking a year-over-year increase of 9.81%. This contributed to the annual value of $189.4 million for FY2025, which is 5.41% up from last year.
  • As of Q3 2025, BIO-TECHNE's Inventory stood at $203.2 million, which was up 7.25% from $189.4 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Inventory ranged from a high of $203.2 million in Q3 2025 and a low of $110.0 million during Q1 2021.
  • For the 3-year period, BIO-TECHNE's Inventory averaged around $184.0 million, with its median value being $185.0 million (2024).
  • As far as peak fluctuations go, BIO-TECHNE's Inventory skyrocketed by 32.10% in 2023, and later fell by 0.56% in 2024.
  • BIO-TECHNE's Inventory (Quarterly) stood at $121.9 million in 2021, then skyrocketed by 31.49% to $160.2 million in 2022, then grew by 12.86% to $180.8 million in 2023, then increased by 4.17% to $188.4 million in 2024, then climbed by 9.81% to $203.2 million in 2025.
  • Its Inventory stands at $203.2 million for Q3 2025, versus $189.4 million for Q2 2025 and $191.1 million for Q1 2025.